229 related articles for article (PubMed ID: 33864796)
1. Challenges and Opportunities in IBD Clinical Trial Design.
Dubinsky MC; Collins R; Abreu MT;
Gastroenterology; 2021 Aug; 161(2):400-404. PubMed ID: 33864796
[No Abstract] [Full Text] [Related]
2. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD.
Le Berre C; Peyrin-Biroulet L;
Gastroenterology; 2021 Apr; 160(5):1452-1460.e21. PubMed ID: 33421515
[TBL] [Abstract][Full Text] [Related]
3. How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases.
Schreiber S; Vermeire S
Gastroenterology; 2016 May; 150(5):1061-1066. PubMed ID: 27018485
[No Abstract] [Full Text] [Related]
4. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Turner D; Ricciuto A; Lewis A; D'Amico F; Dhaliwal J; Griffiths AM; Bettenworth D; Sandborn WJ; Sands BE; Reinisch W; Schölmerich J; Bemelman W; Danese S; Mary JY; Rubin D; Colombel JF; Peyrin-Biroulet L; Dotan I; Abreu MT; Dignass A;
Gastroenterology; 2021 Apr; 160(5):1570-1583. PubMed ID: 33359090
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
Kirsner JB
Dis Mon; 1991 Nov; 37(11):669-746. PubMed ID: 1935537
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.
Yu YR; Rodriguez JR
Semin Pediatr Surg; 2017 Dec; 26(6):349-355. PubMed ID: 29126502
[TBL] [Abstract][Full Text] [Related]
7. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review.
Gisbert JP; Chaparro M
J Crohns Colitis; 2019 Mar; 13(3):374-384. PubMed ID: 30307487
[TBL] [Abstract][Full Text] [Related]
8. [The state of health care and health care paths in inflammatory bowel disease (Crohn's disease and ulcerative colitis)].
Preiss JC; Blumenstein I; Zeuzem S; Zeitz M
Z Gastroenterol; 2009 Jun; 47(6):529-30. PubMed ID: 19533543
[No Abstract] [Full Text] [Related]
9. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice.
Levesque BG; Sandborn WJ; Ruel J; Feagan BG; Sands BE; Colombel JF
Gastroenterology; 2015 Jan; 148(1):37-51.e1. PubMed ID: 25127678
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
[TBL] [Abstract][Full Text] [Related]
11. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
[TBL] [Abstract][Full Text] [Related]
12. The Crohn's Disease-Ulcerative Colitis Clinical Appraisal.
D'Haens G; Bressler B; Danese S; Gibson P; Hanauer SB; Sandborn W
Clin Gastroenterol Hepatol; 2016 Apr; 14(4):638-9. PubMed ID: 26850690
[No Abstract] [Full Text] [Related]
13. Update in pediatric inflammatory bowel disease.
Rabizadeh S; Dubinsky M
Rheum Dis Clin North Am; 2013 Nov; 39(4):789-99. PubMed ID: 24182855
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease. Part I: Nature and pathogenesis.
Kirsner JB
Dis Mon; 1991 Oct; 37(10):605-66. PubMed ID: 1893828
[TBL] [Abstract][Full Text] [Related]
15. [Inflammatory bowel disease].
Vucelić B
Reumatizam; 2013; 60(2):13-23. PubMed ID: 24979991
[TBL] [Abstract][Full Text] [Related]
16. The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials.
Peyrin-Biroulet L; Gower-Rousseau C
J Crohns Colitis; 2016 Dec; 10(12):1375-1377. PubMed ID: 27664272
[No Abstract] [Full Text] [Related]
17. [Retrospective analysis of case histories of patients with ulcerative colitis and Crohn's disease].
Zvirbliene A; Kiudelis G; Kupcinskas L
Medicina (Kaunas); 2003; 39(8):745-50. PubMed ID: 12960453
[TBL] [Abstract][Full Text] [Related]
18. Salivary Stress/Immunological Markers in Crohn's Disease and Ulcerative Colitis.
Finamore A; Peluso I; Cauli O
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202858
[TBL] [Abstract][Full Text] [Related]
19. Ulcerative colitis and Crohn's colitis: differential diagnosis and treatment.
Northfield TC
Drugs; 1977 Sep; 14(3):198-206. PubMed ID: 332482
[No Abstract] [Full Text] [Related]
20. Inflammatory bowel disease. A clinical review of Crohn's disease and ulcerative colitis.
Buch KE
Adv Nurse Pract; 2007 Jul; 15(7):57-60. PubMed ID: 19998998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
